Hong SJ - Search Results

1

Dynamic Risk Stratification in Stage I Papillary Thyroid Cancer Patients Younger Than 45 Years of Age.

Sung TY, Cho JW, Lee YM, Lee YH, Kwon H, Jeon MJ, Kim WG, Choi YJ, Song DE, Chung KW, Yoon JH, Hong SJ. Sung TY, et al. Among authors: hong sj. Thyroid. 2017 Nov;27(11):1400-1407. doi: 10.1089/thy.2017.0199. Epub 2017 Oct 17. Thyroid. 2017. PMID: 28847226

2

Effects of therapeutic doses of 131I in thyroid papillary carcinoma patients with elevated thyroglobulin level and negative 131I whole-body scan: comparative study.

Koh JM, Kim ES, Ryu JS, Hong SJ, Kim WB, Shong YK. Koh JM, et al. Among authors: hong sj. Clin Endocrinol (Oxf). 2003 Apr;58(4):421-7. doi: 10.1046/j.1365-2265.2003.01733.x. Clin Endocrinol (Oxf). 2003. PMID: 12641624

3

Ultrasonographic screening for detection of thyroid cancer in patients with Graves' disease.

Kim WB, Han SM, Kim TY, Nam-Goong IS, Gong G, Lee HK, Hong SJ, Shong YK. Kim WB, et al. Among authors: hong sj. Clin Endocrinol (Oxf). 2004 Jun;60(6):719-25. doi: 10.1111/j.1365-2265.2004.02043.x. Clin Endocrinol (Oxf). 2004. PMID: 15163336

4

Completion thyroidectomy in patients with thyroid cancer who initially underwent unilateral operation.

Kim ES, Kim TY, Koh JM, Kim YI, Hong SJ, Kim WB, Shong YK. Kim ES, et al. Among authors: hong sj. Clin Endocrinol (Oxf). 2004 Jul;61(1):145-8. doi: 10.1111/j.1365-2265.2004.02065.x. Clin Endocrinol (Oxf). 2004. PMID: 15212657

5

Serum thyroglobulin levels at the time of 131I remnant ablation just after thyroidectomy are useful for early prediction of clinical recurrence in low-risk patients with differentiated thyroid carcinoma.

Kim TY, Kim WB, Kim ES, Ryu JS, Yeo JS, Kim SC, Hong SJ, Shong YK. Kim TY, et al. Among authors: hong sj. J Clin Endocrinol Metab. 2005 Mar;90(3):1440-5. doi: 10.1210/jc.2004-1771. Epub 2004 Dec 21. J Clin Endocrinol Metab. 2005. PMID: 15613412

6

The BRAF mutation is useful for prediction of clinical recurrence in low-risk patients with conventional papillary thyroid carcinoma.

Kim TY, Kim WB, Rhee YS, Song JY, Kim JM, Gong G, Lee S, Kim SY, Kim SC, Hong SJ, Shong YK. Kim TY, et al. Among authors: hong sj. Clin Endocrinol (Oxf). 2006 Sep;65(3):364-8. doi: 10.1111/j.1365-2265.2006.02605.x. Clin Endocrinol (Oxf). 2006. PMID: 16918957

7

Lymphovascular invasion is associated with lateral cervical lymph node metastasis in papillary thyroid carcinoma.

Kim JM, Kim TY, Kim WB, Gong G, Kim SC, Hong SJ, Shong YK. Kim JM, et al. Among authors: hong sj. Laryngoscope. 2006 Nov;116(11):2081-5. doi: 10.1097/01.mlg.0000242118.79647.a9. Laryngoscope. 2006. PMID: 17075398

8

Change of serum antithyroglobulin antibody levels is useful for prediction of clinical recurrence in thyroglobulin-negative patients with differentiated thyroid carcinoma.

Kim WG, Yoon JH, Kim WB, Kim TY, Kim EY, Kim JM, Ryu JS, Gong G, Hong SJ, Shong YK. Kim WG, et al. Among authors: hong sj. J Clin Endocrinol Metab. 2008 Dec;93(12):4683-9. doi: 10.1210/jc.2008-0962. Epub 2008 Sep 23. J Clin Endocrinol Metab. 2008. PMID: 18812478

9

Prognostic parameters for recurrence of papillary thyroid microcarcinoma.

Kim TY, Hong SJ, Kim JM, Kim WG, Gong G, Ryu JS, Kim WB, Yun SC, Shong YK. Kim TY, et al. Among authors: hong sj. BMC Cancer. 2008 Oct 14;8:296. doi: 10.1186/1471-2407-8-296. BMC Cancer. 2008. PMID: 18851763 Free PMC article.

10

Redifferentiation therapy with 13-cis retinoic acids in radioiodine-resistant thyroid cancer.

Kim WG, Kim EY, Kim TY, Ryu JS, Hong SJ, Kim WB, Shong YK. Kim WG, et al. Among authors: hong sj. Endocr J. 2009;56(1):105-12. doi: 10.1507/endocrj.k08e-254. Epub 2008 Oct 11. Endocr J. 2009. PMID: 18854619 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,791 results

Search Page

Filters